3
项与 Allogeneic anti-CD19 CAR-T (Tianjin First Center Hospital) 相关的临床试验A single-center, single-arm, open-label, dose escalation study for evaluating the safety & preliminary anti-tumor activity of CD19 allogeneic chimeric antigen receptor T cells (CD19 Allo-CAR-T) in the treatment of patients with relapsed / refractory B cell malignancies
multi-center clinical study of CD19+ -car-t cells combined with chemotherapy in the treatment of the newly diagnosed high-risk adult PH (-) B-ALL
A clinical trial for safety and efficient of CD19CART cells combination with nivolumab in the treatment of refractory/relapsed B cell lymphoma
100 项与 Allogeneic anti-CD19 CAR-T (Tianjin First Center Hospital) 相关的临床结果
100 项与 Allogeneic anti-CD19 CAR-T (Tianjin First Center Hospital) 相关的转化医学
100 项与 Allogeneic anti-CD19 CAR-T (Tianjin First Center Hospital) 相关的专利（医药）
100 项与 Allogeneic anti-CD19 CAR-T (Tianjin First Center Hospital) 相关的药物交易
